Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE DIN 02563266

Status: Marketed
Holder: STERIMAX INC
Molecule: CISATRACURIUM (CISATRACURIUM BESYLATE)

Health Canada record

Active ingredient(s)CISATRACURIUM (CISATRACURIUM BESYLATE) 2 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCM03AC11 CISATRACURIUM
Original market date13-Jan-2026
Current status date13-Jan-2026
SourceHealth Canada DPD

Establishment licence of the holder

Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CISATRACURIUM (CISATRACURIUM BESYLATE)

DINProductCompanyFormStrengthStatus
02423782CISATRACURIUM BESYLATE INJECTION MULTI-DOSEFRESENIUS KABI CANADA LTDSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGApproved
02423774CISATRACURIUM BESYLATE INJECTION SINGLE DOSEFRESENIUS KABI CANADA LTDSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGApproved
02408813CISATRACURIUM BESYLATE INJECTION USP MULTIDOSEOMEGA LABORATORIES LIMITEDSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGMarketed
02557665CISATRACURIUM BESYLATE INJECTION, USP MULTI-DOSEHIKMA CANADA LIMITEDSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGApproved
02408848AJ-CISATRACURIUMAGILA JAMP CANADA INCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Pre Market
02408856AJ-CISATRACURIUMAGILA JAMP CANADA INCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Pre Market
02406519CISATRACURIUM BESYLATE INJECTIONMYLAN PHARMACEUTICALS ULCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Pre Market
02425718CISATRACURIUM BESYLATE INJECTIONPFIZER CANADA ULCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Post Market
02457385CISATRACURIUM BESYLATE INJECTIONACCORD HEALTHCARE INCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Pre Market
02406527CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE)MYLAN PHARMACEUTICALS ULCSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Pre Market
02408805CISATRACURIUM OMEGA SINGLE DOSEOMEGA LABORATORIES LIMITEDSolutionCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGDormant
02229422NIMBEXABBVIE CORPORATIONLiquidCISATRACURIUM (CISATRACURIUM BESYLATE) 2 MGCancelled Post Market
02229423NIMBEX 10MG/MLABBOTT LABORATORIES, LIMITEDLiquidCISATRACURIUM (CISATRACURIUM BESYLATE) 10 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
364812025-12-04Abbreviated New Drug Submission (ANDS)
Request a quote for CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE

How to read a Canadian DIN record